Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
What is IV therapy used for
Singapore faces a high prevalence of diabetes, with approximately 1 in 9 Singaporeans affected by the condition
Hillcrofts team ensures patients are monitored closely to track progress, manage dosage, and minimize potential side effects
NICE recommends GLP-1 therapy for type 2 diabetes (NG28) when: HbA1c remains elevated despite dual therapy with metformin and another oral agent The patient has a BMI of 35 kg/m or higher (or lower thresholds for certain ethnic groups) Significant weight loss would benefit other obesity-related comorbidities Insulin therapy poses specific risks or is declined by the patient For weight management, NICE has approved specific GLP-1 receptor agonists through Technology Appraisals
US$ 21.16
US$ 24.46
US$ 29.59
US$ 27.80
US$ 21.19
